iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(1H-imidazol-5-yl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide

C43H35FeN11O4 — CID 20603230

IUPACiron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(1H-imidazol-5-yl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide
SMILESO=C(NCCCCc1cnc[nH]1)c1cccc2c1-c1nc-2nc2[n-]c(nc3nc(nc4[n-]c(n1)c1ccc(CO)cc41)-c1cc(CO)ccc1-3)c1c2CC=C(CO)C1.[Fe+2]
InChIInChI=1S/C43H36N11O4.Fe/c55-18-22-7-10-26-31(14-22)39-48-35(26)47-38-29-5-3-6-30(43(58)45-13-2-1-4-25-17-44-21-46-25)34(29)42(54-38)53-37-28-12-9-24(20-57)16-33(28)41(51-37)52-40-32-15-23(19-56)8-11-27(32)36(49-39)50-40;/h3,5-9,11-12,15-17,21,55-57H,1-2,4,10,13-14,18-20H2,(H3-,44,45,46,47,48,49,50,51,52,53,54,58);/q-1;+2/p-1
InChIKeyWOWDMQPJTYKJDQ-UHFFFAOYSA-M
MW825.67 g/mol
LogP4.45
Rot. Bonds9

About iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(1H-imidazol-5-yl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide

iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(1H-imidazol-5-yl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide (PubChem CID 20603230) has the molecular formula C43H35FeN11O4 and a molecular weight of 825.67 g/mol. Its IUPAC name is iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(1H-imidazol-5-yl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide.

Molecular Properties

Compound Nameiron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(1H-imidazol-5-yl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide
PubChem CID20603230
Molecular FormulaC43H35FeN11O4
Molecular Weight825.67 g/mol
Exact Mass825.22
IUPAC Nameiron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(1H-imidazol-5-yl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide
SMILESO=C(NCCCCc1cnc[nH]1)c1cccc2c1-c1nc-2nc2[n-]c(nc3nc(nc4[n-]c(n1)c1ccc(CO)cc41)-c1cc(CO)ccc1-3)c1c2CC=C(CO)C1.[Fe+2]
InChIInChI=1S/C43H36N11O4.Fe/c55-18-22-7-10-26-31(14-22)39-48-35(26)47-38-29-5-3-6-30(43(58)45-13-2-1-4-25-17-44-21-46-25)34(29)42(54-38)53-37-28-12-9-24(20-57)16-33(28)41(51-37)52-40-32-15-23(19-56)8-11-27(32)36(49-39)50-40;/h3,5-9,11-12,15-17,21,55-57H,1-2,4,10,13-14,18-20H2,(H3-,44,45,46,47,48,49,50,51,52,53,54,58);/q-1;+2/p-1
InChIKeyWOWDMQPJTYKJDQ-UHFFFAOYSA-M
XLogP4.45
TPSA224.01 Ų
H-Bond Donors5
H-Bond Acceptors11
Rotatable Bonds9
Heavy Atoms59
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500825.67
LogP ≤ 54.45
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(1H-imidazol-5-yl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(1H-imidazol-5-yl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide?
The IUPAC name of iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(1H-imidazol-5-yl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide (CID 20603230) is iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(1H-imidazol-5-yl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide.
What is the SMILES notation for iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(1H-imidazol-5-yl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide?
The canonical SMILES for iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(1H-imidazol-5-yl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide is O=C(NCCCCc1cnc[nH]1)c1cccc2c1-c1nc-2nc2[n-]c(nc3nc(nc4[n-]c(n1)c1ccc(CO)cc41)-c1cc(CO)ccc1-3)c1c2CC=C(CO)C1.[Fe+2].
What is the InChIKey of iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(1H-imidazol-5-yl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide?
The InChIKey is WOWDMQPJTYKJDQ-UHFFFAOYSA-M. The full InChI is InChI=1S/C43H36N11O4.Fe/c55-18-22-7-10-26-31(14-22)39-48-35(26)47-38-29-5-3-6-30(43(58)45-13-2-1-4-25-17-44-21-46-25)34(29)42(54-38)53-37-28-12-9-24(20-57)16-33(28)41(51-37)52-40-32-15-23(19-56)8-11-27(32)36(49-39)50-40;/h3,5-9,11-12,15-17,21,55-57H,1-2,4,10,13-14,18-20H2,(H3-,44,45,46,47,48,49,50,51,52,53,54,58);/q-1;+2/p-1.
What are the key properties of iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(1H-imidazol-5-yl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide?
iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(1H-imidazol-5-yl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide has a molecular weight of 825.67 g/mol, XLogP of 4.45, 9 rotatable bonds, 5 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(1H-imidazol-5-yl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide is sourced from PubChem (CID 20603230), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).